nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenobarbital—CYP4A11—Cisplatin—testicular cancer	0.0761	0.0903	CbGbCtD
Phenobarbital—CYP2C18—Ifosfamide—testicular cancer	0.0687	0.0815	CbGbCtD
Phenobarbital—ABCC1—Dactinomycin—testicular cancer	0.0391	0.0464	CbGbCtD
Phenobarbital—ABCC3—Cisplatin—testicular cancer	0.0366	0.0434	CbGbCtD
Phenobarbital—ABCC3—Etoposide—testicular cancer	0.0359	0.0426	CbGbCtD
Phenobarbital—ABCB11—Vinblastine—testicular cancer	0.0345	0.0409	CbGbCtD
Phenobarbital—CYP2A6—Ifosfamide—testicular cancer	0.0334	0.0396	CbGbCtD
Phenobarbital—ABCC1—Epirubicin—testicular cancer	0.0283	0.0336	CbGbCtD
Phenobarbital—ABCC3—Doxorubicin—testicular cancer	0.0245	0.0291	CbGbCtD
Phenobarbital—ABCC1—Vinblastine—testicular cancer	0.0245	0.0291	CbGbCtD
Phenobarbital—ABCC3—Methotrexate—testicular cancer	0.0237	0.0282	CbGbCtD
Phenobarbital—CYP3A7—Ifosfamide—testicular cancer	0.0228	0.0271	CbGbCtD
Phenobarbital—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0228	0.0271	CbGbCtD
Phenobarbital—ABCC1—Etoposide—testicular cancer	0.0221	0.0262	CbGbCtD
Phenobarbital—CYP2B6—Ifosfamide—testicular cancer	0.0217	0.0258	CbGbCtD
Phenobarbital—CYP1B1—Doxorubicin—testicular cancer	0.0212	0.0251	CbGbCtD
Phenobarbital—ABCB11—Doxorubicin—testicular cancer	0.0212	0.0251	CbGbCtD
Phenobarbital—ABCC2—Carboplatin—testicular cancer	0.0195	0.0231	CbGbCtD
Phenobarbital—ABCC2—Vinblastine—testicular cancer	0.0181	0.0215	CbGbCtD
Phenobarbital—CHRFAM7A—corpus luteum—testicular cancer	0.0173	0.284	CbGeAlD
Phenobarbital—CYP3A5—Ifosfamide—testicular cancer	0.0171	0.0203	CbGbCtD
Phenobarbital—ABCC2—Cisplatin—testicular cancer	0.0166	0.0197	CbGbCtD
Phenobarbital—CYP2C8—Ifosfamide—testicular cancer	0.0165	0.0195	CbGbCtD
Phenobarbital—ABCC2—Etoposide—testicular cancer	0.0163	0.0194	CbGbCtD
Phenobarbital—ABCC1—Doxorubicin—testicular cancer	0.015	0.0179	CbGbCtD
Phenobarbital—ABCC1—Methotrexate—testicular cancer	0.0146	0.0173	CbGbCtD
Phenobarbital—CHRNA7—corpus luteum—testicular cancer	0.014	0.229	CbGeAlD
Phenobarbital—CYP2C19—Ifosfamide—testicular cancer	0.0138	0.0164	CbGbCtD
Phenobarbital—CYP2C9—Ifosfamide—testicular cancer	0.0115	0.0136	CbGbCtD
Phenobarbital—ABCC2—Doxorubicin—testicular cancer	0.0111	0.0132	CbGbCtD
Phenobarbital—ABCC2—Methotrexate—testicular cancer	0.0108	0.0128	CbGbCtD
Phenobarbital—CYP2B6—Cisplatin—testicular cancer	0.0106	0.0125	CbGbCtD
Phenobarbital—CYP2E1—Etoposide—testicular cancer	0.0105	0.0125	CbGbCtD
Phenobarbital—ABCB1—Dactinomycin—testicular cancer	0.00943	0.0112	CbGbCtD
Phenobarbital—CYP3A5—Etoposide—testicular cancer	0.00818	0.00971	CbGbCtD
Phenobarbital—CYP2C8—Etoposide—testicular cancer	0.00787	0.00933	CbGbCtD
Phenobarbital—CYP2B6—Doxorubicin—testicular cancer	0.00708	0.0084	CbGbCtD
Phenobarbital—CYP3A4—Ifosfamide—testicular cancer	0.00667	0.00792	CbGbCtD
Phenobarbital—CYP1A2—Etoposide—testicular cancer	0.00609	0.00722	CbGbCtD
Phenobarbital—ABCB1—Vinblastine—testicular cancer	0.00591	0.00701	CbGbCtD
Phenobarbital—CYP2C9—Cisplatin—testicular cancer	0.00558	0.00662	CbGbCtD
Phenobarbital—ABCB1—Cisplatin—testicular cancer	0.00542	0.00643	CbGbCtD
Phenobarbital—ABCB1—Etoposide—testicular cancer	0.00532	0.00632	CbGbCtD
Phenobarbital—ABCB1—Doxorubicin—testicular cancer	0.00363	0.00431	CbGbCtD
Phenobarbital—CYP3A4—Vinblastine—testicular cancer	0.00354	0.0042	CbGbCtD
Phenobarbital—ABCB1—Methotrexate—testicular cancer	0.00352	0.00417	CbGbCtD
Phenobarbital—CYP3A4—Etoposide—testicular cancer	0.00319	0.00378	CbGbCtD
Phenobarbital—CYP3A4—Doxorubicin—testicular cancer	0.00218	0.00258	CbGbCtD
Phenobarbital—GRIA2—embryo—testicular cancer	0.00201	0.033	CbGeAlD
Phenobarbital—SLCO2A1—seminal vesicle—testicular cancer	0.00169	0.0278	CbGeAlD
Phenobarbital—CYP4B1—female gonad—testicular cancer	0.00166	0.0273	CbGeAlD
Phenobarbital—CYP4B1—testis—testicular cancer	0.00147	0.0242	CbGeAlD
Phenobarbital—CYP2A6—seminal vesicle—testicular cancer	0.00139	0.0228	CbGeAlD
Phenobarbital—CYP4B1—lymph node—testicular cancer	0.00107	0.0175	CbGeAlD
Phenobarbital—ABCB11—testis—testicular cancer	0.00106	0.0175	CbGeAlD
Phenobarbital—CHRFAM7A—female gonad—testicular cancer	0.00101	0.0166	CbGeAlD
Phenobarbital—SLCO2A1—female gonad—testicular cancer	0.000993	0.0163	CbGeAlD
Phenobarbital—GRIA2—testis—testicular cancer	0.000982	0.0161	CbGeAlD
Phenobarbital—ABCC1—seminal vesicle—testicular cancer	0.000914	0.015	CbGeAlD
Phenobarbital—CHRFAM7A—testis—testicular cancer	0.000895	0.0147	CbGeAlD
Phenobarbital—SLCO2A1—testis—testicular cancer	0.000881	0.0145	CbGeAlD
Phenobarbital—CHRNA7—female gonad—testicular cancer	0.000815	0.0134	CbGeAlD
Phenobarbital—ABCC3—female gonad—testicular cancer	0.000763	0.0125	CbGeAlD
Phenobarbital—CYP1B1—gonad—testicular cancer	0.000734	0.0121	CbGeAlD
Phenobarbital—CHRNA7—testis—testicular cancer	0.000723	0.0119	CbGeAlD
Phenobarbital—ABCC3—testis—testicular cancer	0.000676	0.0111	CbGeAlD
Phenobarbital—CYP2E1—seminal vesicle—testicular cancer	0.000655	0.0108	CbGeAlD
Phenobarbital—SLCO2A1—lymph node—testicular cancer	0.000638	0.0105	CbGeAlD
Phenobarbital—CYP1B1—female gonad—testicular cancer	0.000597	0.0098	CbGeAlD
Phenobarbital—ABCC2—testis—testicular cancer	0.00054	0.00888	CbGeAlD
Phenobarbital—ABCC1—female gonad—testicular cancer	0.000537	0.00882	CbGeAlD
Phenobarbital—CYP1B1—testis—testicular cancer	0.000529	0.00869	CbGeAlD
Phenobarbital—CYP2B6—gonad—testicular cancer	0.000504	0.00828	CbGeAlD
Phenobarbital—ABCC3—lymph node—testicular cancer	0.00049	0.00805	CbGeAlD
Phenobarbital—ABCC1—testis—testicular cancer	0.000476	0.00782	CbGeAlD
Phenobarbital—Stevens-Johnson syndrome—Dactinomycin—testicular cancer	0.000476	0.00494	CcSEcCtD
Phenobarbital—Angioedema—Chlorambucil—testicular cancer	0.000475	0.00493	CcSEcCtD
Phenobarbital—Necrosis—Methotrexate—testicular cancer	0.000474	0.00492	CcSEcCtD
Phenobarbital—Irritability—Cisplatin—testicular cancer	0.00047	0.00488	CcSEcCtD
Phenobarbital—Nystagmus—Doxorubicin—testicular cancer	0.000451	0.00468	CcSEcCtD
Phenobarbital—Blister—Doxorubicin—testicular cancer	0.000447	0.00464	CcSEcCtD
Phenobarbital—Necrosis—Epirubicin—testicular cancer	0.000444	0.00461	CcSEcCtD
Phenobarbital—Apnoea—Methotrexate—testicular cancer	0.000439	0.00456	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Ifosfamide—testicular cancer	0.000436	0.00453	CcSEcCtD
Phenobarbital—Renal failure—Ifosfamide—testicular cancer	0.000432	0.00449	CcSEcCtD
Phenobarbital—Hepatitis—Dactinomycin—testicular cancer	0.000431	0.00448	CcSEcCtD
Phenobarbital—Vertigo—Vinblastine—testicular cancer	0.000428	0.00444	CcSEcCtD
Phenobarbital—Confusional state—Chlorambucil—testicular cancer	0.000428	0.00444	CcSEcCtD
Phenobarbital—Extravasation—Methotrexate—testicular cancer	0.000426	0.00443	CcSEcCtD
Phenobarbital—CYP1A1—female gonad—testicular cancer	0.000422	0.00693	CbGeAlD
Phenobarbital—Liver injury—Epirubicin—testicular cancer	0.000414	0.0043	CcSEcCtD
Phenobarbital—CYP3A5—female gonad—testicular cancer	0.000412	0.00677	CbGeAlD
Phenobarbital—Necrosis—Doxorubicin—testicular cancer	0.00041	0.00426	CcSEcCtD
Phenobarbital—Erythema multiforme—Dactinomycin—testicular cancer	0.000408	0.00423	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Etoposide—testicular cancer	0.000406	0.00422	CcSEcCtD
Phenobarbital—CYP2C8—testis—testicular cancer	0.000405	0.00666	CbGeAlD
Phenobarbital—Delirium—Epirubicin—testicular cancer	0.000405	0.0042	CcSEcCtD
Phenobarbital—Erythema—Bleomycin—testicular cancer	0.000402	0.00418	CcSEcCtD
Phenobarbital—Bradycardia—Ifosfamide—testicular cancer	0.000402	0.00418	CcSEcCtD
Phenobarbital—Extravasation—Epirubicin—testicular cancer	0.000399	0.00414	CcSEcCtD
Phenobarbital—ABCB1—embryo—testicular cancer	0.000397	0.00652	CbGeAlD
Phenobarbital—Hepatitis—Ifosfamide—testicular cancer	0.000395	0.0041	CcSEcCtD
Phenobarbital—Hallucination—Ifosfamide—testicular cancer	0.000393	0.00408	CcSEcCtD
Phenobarbital—ABCC2—lymph node—testicular cancer	0.000392	0.00643	CbGeAlD
Phenobarbital—CYP1B1—lymph node—testicular cancer	0.000384	0.0063	CbGeAlD
Phenobarbital—Liver injury—Doxorubicin—testicular cancer	0.000383	0.00398	CcSEcCtD
Phenobarbital—Thinking abnormal—Epirubicin—testicular cancer	0.00038	0.00395	CcSEcCtD
Phenobarbital—Hypocalcaemia—Epirubicin—testicular cancer	0.00038	0.00395	CcSEcCtD
Phenobarbital—Respiratory failure—Methotrexate—testicular cancer	0.000379	0.00393	CcSEcCtD
Phenobarbital—Erythema—Dactinomycin—testicular cancer	0.000375	0.0039	CcSEcCtD
Phenobarbital—Delirium—Doxorubicin—testicular cancer	0.000375	0.00389	CcSEcCtD
Phenobarbital—Erythema multiforme—Ifosfamide—testicular cancer	0.000373	0.00388	CcSEcCtD
Phenobarbital—ABCB1—seminal vesicle—testicular cancer	0.000373	0.00613	CbGeAlD
Phenobarbital—Renal failure—Cisplatin—testicular cancer	0.000373	0.00387	CcSEcCtD
Phenobarbital—Extravasation—Doxorubicin—testicular cancer	0.000369	0.00383	CcSEcCtD
Phenobarbital—CYP2B6—testis—testicular cancer	0.000364	0.00597	CbGeAlD
Phenobarbital—Pain—Chlorambucil—testicular cancer	0.000363	0.00377	CcSEcCtD
Phenobarbital—Depressed level of consciousness—Methotrexate—testicular cancer	0.000359	0.00373	CcSEcCtD
Phenobarbital—Hypocalcaemia—Doxorubicin—testicular cancer	0.000352	0.00365	CcSEcCtD
Phenobarbital—Thinking abnormal—Doxorubicin—testicular cancer	0.000352	0.00365	CcSEcCtD
Phenobarbital—Feeling abnormal—Chlorambucil—testicular cancer	0.00035	0.00363	CcSEcCtD
Phenobarbital—Hepatocellular injury—Epirubicin—testicular cancer	0.000348	0.00362	CcSEcCtD
Phenobarbital—Bradycardia—Cisplatin—testicular cancer	0.000347	0.0036	CcSEcCtD
Phenobarbital—Injection site reaction—Epirubicin—testicular cancer	0.000346	0.00359	CcSEcCtD
Phenobarbital—ABCC1—lymph node—testicular cancer	0.000345	0.00567	CbGeAlD
Phenobarbital—Stevens-Johnson syndrome—Etoposide—testicular cancer	0.000344	0.00358	CcSEcCtD
Phenobarbital—Erythema—Ifosfamide—testicular cancer	0.000344	0.00357	CcSEcCtD
Phenobarbital—Myalgia—Bleomycin—testicular cancer	0.000342	0.00356	CcSEcCtD
Phenobarbital—Renal failure—Etoposide—testicular cancer	0.000342	0.00355	CcSEcCtD
Phenobarbital—CYP2E1—testis—testicular cancer	0.000341	0.0056	CbGeAlD
Phenobarbital—Coma—Methotrexate—testicular cancer	0.00034	0.00353	CcSEcCtD
Phenobarbital—Urticaria—Chlorambucil—testicular cancer	0.000337	0.0035	CcSEcCtD
Phenobarbital—Body temperature increased—Chlorambucil—testicular cancer	0.000335	0.00348	CcSEcCtD
Phenobarbital—Pain—Vinblastine—testicular cancer	0.000332	0.00345	CcSEcCtD
Phenobarbital—Constipation—Vinblastine—testicular cancer	0.000332	0.00345	CcSEcCtD
Phenobarbital—Confusional state—Bleomycin—testicular cancer	0.000331	0.00344	CcSEcCtD
Phenobarbital—Hepatocellular injury—Doxorubicin—testicular cancer	0.000322	0.00335	CcSEcCtD
Phenobarbital—Feeling abnormal—Vinblastine—testicular cancer	0.00032	0.00333	CcSEcCtD
Phenobarbital—Injection site reaction—Doxorubicin—testicular cancer	0.00032	0.00333	CcSEcCtD
Phenobarbital—Myalgia—Dactinomycin—testicular cancer	0.000319	0.00332	CcSEcCtD
Phenobarbital—Coma—Epirubicin—testicular cancer	0.000318	0.0033	CcSEcCtD
Phenobarbital—Agitation—Ifosfamide—testicular cancer	0.000316	0.00328	CcSEcCtD
Phenobarbital—Angioedema—Ifosfamide—testicular cancer	0.000314	0.00326	CcSEcCtD
Phenobarbital—Hypersensitivity—Chlorambucil—testicular cancer	0.000313	0.00325	CcSEcCtD
Phenobarbital—Vertigo—Ifosfamide—testicular cancer	0.000309	0.00321	CcSEcCtD
Phenobarbital—Hypotension—Bleomycin—testicular cancer	0.000307	0.00319	CcSEcCtD
Phenobarbital—Mental disability—Epirubicin—testicular cancer	0.000302	0.00314	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.000299	0.00311	CcSEcCtD
Phenobarbital—Erythema—Cisplatin—testicular cancer	0.000296	0.00308	CcSEcCtD
Phenobarbital—Erythema multiforme—Etoposide—testicular cancer	0.000295	0.00306	CcSEcCtD
Phenobarbital—Coma—Doxorubicin—testicular cancer	0.000294	0.00306	CcSEcCtD
Phenobarbital—Myalgia—Ifosfamide—testicular cancer	0.000293	0.00304	CcSEcCtD
Phenobarbital—Arthralgia—Ifosfamide—testicular cancer	0.000293	0.00304	CcSEcCtD
Phenobarbital—Hypersensitivity—Vinblastine—testicular cancer	0.000286	0.00297	CcSEcCtD
Phenobarbital—Dermatitis exfoliative—Methotrexate—testicular cancer	0.000286	0.00297	CcSEcCtD
Phenobarbital—Confusional state—Ifosfamide—testicular cancer	0.000283	0.00294	CcSEcCtD
Phenobarbital—Pain—Bleomycin—testicular cancer	0.000281	0.00292	CcSEcCtD
Phenobarbital—Mental disability—Doxorubicin—testicular cancer	0.00028	0.0029	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000279	0.0029	CcSEcCtD
Phenobarbital—Lethargy—Methotrexate—testicular cancer	0.000276	0.00286	CcSEcCtD
Phenobarbital—CYP1A1—lymph node—testicular cancer	0.000271	0.00445	CbGeAlD
Phenobarbital—Feeling abnormal—Bleomycin—testicular cancer	0.000271	0.00281	CcSEcCtD
Phenobarbital—Vomiting—Chlorambucil—testicular cancer	0.00027	0.0028	CcSEcCtD
Phenobarbital—ABCB1—gonad—testicular cancer	0.00027	0.00443	CbGeAlD
Phenobarbital—Dermatitis exfoliative—Epirubicin—testicular cancer	0.000268	0.00278	CcSEcCtD
Phenobarbital—Dermatitis bullous—Epirubicin—testicular cancer	0.000264	0.00275	CcSEcCtD
Phenobarbital—Hypotension—Ifosfamide—testicular cancer	0.000262	0.00272	CcSEcCtD
Phenobarbital—Pain—Dactinomycin—testicular cancer	0.000262	0.00272	CcSEcCtD
Phenobarbital—Urticaria—Bleomycin—testicular cancer	0.000261	0.00271	CcSEcCtD
Phenobarbital—Body temperature increased—Bleomycin—testicular cancer	0.00026	0.0027	CcSEcCtD
Phenobarbital—Lethargy—Epirubicin—testicular cancer	0.000258	0.00268	CcSEcCtD
Phenobarbital—Irritability—Methotrexate—testicular cancer	0.000258	0.00268	CcSEcCtD
Phenobarbital—Dizziness—Vinblastine—testicular cancer	0.000257	0.00267	CcSEcCtD
Phenobarbital—Mood swings—Methotrexate—testicular cancer	0.000256	0.00266	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000256	0.00265	CcSEcCtD
Phenobarbital—Ataxia—Methotrexate—testicular cancer	0.000254	0.00264	CcSEcCtD
Phenobarbital—Myalgia—Cisplatin—testicular cancer	0.000252	0.00262	CcSEcCtD
Phenobarbital—Feeling abnormal—Dactinomycin—testicular cancer	0.000252	0.00262	CcSEcCtD
Phenobarbital—Nausea—Chlorambucil—testicular cancer	0.000252	0.00262	CcSEcCtD
Phenobarbital—Anxiety—Cisplatin—testicular cancer	0.000251	0.00261	CcSEcCtD
Phenobarbital—Somnolence—Ifosfamide—testicular cancer	0.000249	0.00259	CcSEcCtD
Phenobarbital—Affect lability—Epirubicin—testicular cancer	0.000249	0.00258	CcSEcCtD
Phenobarbital—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.000248	0.00257	CcSEcCtD
Phenobarbital—Vomiting—Vinblastine—testicular cancer	0.000247	0.00257	CcSEcCtD
Phenobarbital—Dermatitis bullous—Doxorubicin—testicular cancer	0.000245	0.00254	CcSEcCtD
Phenobarbital—Vertigo—Etoposide—testicular cancer	0.000244	0.00253	CcSEcCtD
Phenobarbital—Headache—Vinblastine—testicular cancer	0.000244	0.00253	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.000243	0.00253	CcSEcCtD
Phenobarbital—Body temperature increased—Dactinomycin—testicular cancer	0.000242	0.00251	CcSEcCtD
Phenobarbital—Hypersensitivity—Bleomycin—testicular cancer	0.000242	0.00251	CcSEcCtD
Phenobarbital—Constipation—Ifosfamide—testicular cancer	0.00024	0.00249	CcSEcCtD
Phenobarbital—Pain—Ifosfamide—testicular cancer	0.00024	0.00249	CcSEcCtD
Phenobarbital—Mood swings—Epirubicin—testicular cancer	0.000239	0.00249	CcSEcCtD
Phenobarbital—Loss of consciousness—Etoposide—testicular cancer	0.000239	0.00248	CcSEcCtD
Phenobarbital—Lethargy—Doxorubicin—testicular cancer	0.000239	0.00248	CcSEcCtD
Phenobarbital—Ataxia—Epirubicin—testicular cancer	0.000238	0.00247	CcSEcCtD
Phenobarbital—Asthma—Methotrexate—testicular cancer	0.000233	0.00242	CcSEcCtD
Phenobarbital—Feeling abnormal—Ifosfamide—testicular cancer	0.000231	0.0024	CcSEcCtD
Phenobarbital—Nausea—Vinblastine—testicular cancer	0.000231	0.0024	CcSEcCtD
Phenobarbital—Affect lability—Doxorubicin—testicular cancer	0.00023	0.00239	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.000228	0.00236	CcSEcCtD
Phenobarbital—Hypotension—Cisplatin—testicular cancer	0.000226	0.00235	CcSEcCtD
Phenobarbital—Hypersensitivity—Dactinomycin—testicular cancer	0.000226	0.00234	CcSEcCtD
Phenobarbital—Confusional state—Etoposide—testicular cancer	0.000223	0.00232	CcSEcCtD
Phenobarbital—Urticaria—Ifosfamide—testicular cancer	0.000223	0.00231	CcSEcCtD
Phenobarbital—Body temperature increased—Ifosfamide—testicular cancer	0.000222	0.0023	CcSEcCtD
Phenobarbital—Mood swings—Doxorubicin—testicular cancer	0.000222	0.0023	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00022	0.00229	CcSEcCtD
Phenobarbital—Ataxia—Doxorubicin—testicular cancer	0.00022	0.00228	CcSEcCtD
Phenobarbital—ABCB1—female gonad—testicular cancer	0.000219	0.0036	CbGeAlD
Phenobarbital—Asthma—Epirubicin—testicular cancer	0.000218	0.00227	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000211	0.00219	CcSEcCtD
Phenobarbital—Vomiting—Bleomycin—testicular cancer	0.000209	0.00217	CcSEcCtD
Phenobarbital—Drowsiness—Methotrexate—testicular cancer	0.000208	0.00216	CcSEcCtD
Phenobarbital—Hypotension—Etoposide—testicular cancer	0.000207	0.00215	CcSEcCtD
Phenobarbital—Rash—Bleomycin—testicular cancer	0.000207	0.00215	CcSEcCtD
Phenobarbital—Pain—Cisplatin—testicular cancer	0.000207	0.00215	CcSEcCtD
Phenobarbital—Dermatitis—Bleomycin—testicular cancer	0.000207	0.00215	CcSEcCtD
Phenobarbital—Hypersensitivity—Ifosfamide—testicular cancer	0.000207	0.00215	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000206	0.00214	CcSEcCtD
Phenobarbital—Renal failure—Methotrexate—testicular cancer	0.000205	0.00212	CcSEcCtD
Phenobarbital—Asthma—Doxorubicin—testicular cancer	0.000202	0.0021	CcSEcCtD
Phenobarbital—Feeling abnormal—Cisplatin—testicular cancer	0.000199	0.00207	CcSEcCtD
Phenobarbital—Somnolence—Etoposide—testicular cancer	0.000197	0.00205	CcSEcCtD
Phenobarbital—Nausea—Bleomycin—testicular cancer	0.000195	0.00203	CcSEcCtD
Phenobarbital—Drowsiness—Epirubicin—testicular cancer	0.000195	0.00202	CcSEcCtD
Phenobarbital—Vomiting—Dactinomycin—testicular cancer	0.000195	0.00202	CcSEcCtD
Phenobarbital—ABCB1—testis—testicular cancer	0.000194	0.00319	CbGeAlD
Phenobarbital—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000193	0.00201	CcSEcCtD
Phenobarbital—Rash—Dactinomycin—testicular cancer	0.000193	0.002	CcSEcCtD
Phenobarbital—Renal failure—Epirubicin—testicular cancer	0.000191	0.00199	CcSEcCtD
Phenobarbital—Body temperature increased—Cisplatin—testicular cancer	0.000191	0.00199	CcSEcCtD
Phenobarbital—Pain—Etoposide—testicular cancer	0.00019	0.00197	CcSEcCtD
Phenobarbital—Constipation—Etoposide—testicular cancer	0.00019	0.00197	CcSEcCtD
Phenobarbital—Hepatitis—Methotrexate—testicular cancer	0.000187	0.00194	CcSEcCtD
Phenobarbital—Dizziness—Ifosfamide—testicular cancer	0.000186	0.00193	CcSEcCtD
Phenobarbital—Feeling abnormal—Etoposide—testicular cancer	0.000183	0.0019	CcSEcCtD
Phenobarbital—Nausea—Dactinomycin—testicular cancer	0.000182	0.00189	CcSEcCtD
Phenobarbital—Drowsiness—Doxorubicin—testicular cancer	0.00018	0.00187	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000179	0.00186	CcSEcCtD
Phenobarbital—Vomiting—Ifosfamide—testicular cancer	0.000178	0.00185	CcSEcCtD
Phenobarbital—Hypersensitivity—Cisplatin—testicular cancer	0.000178	0.00185	CcSEcCtD
Phenobarbital—Bradycardia—Epirubicin—testicular cancer	0.000178	0.00185	CcSEcCtD
Phenobarbital—Renal failure—Doxorubicin—testicular cancer	0.000177	0.00184	CcSEcCtD
Phenobarbital—Rash—Ifosfamide—testicular cancer	0.000177	0.00184	CcSEcCtD
Phenobarbital—Dermatitis—Ifosfamide—testicular cancer	0.000177	0.00184	CcSEcCtD
Phenobarbital—Erythema multiforme—Methotrexate—testicular cancer	0.000177	0.00183	CcSEcCtD
Phenobarbital—Urticaria—Etoposide—testicular cancer	0.000176	0.00183	CcSEcCtD
Phenobarbital—Body temperature increased—Etoposide—testicular cancer	0.000175	0.00182	CcSEcCtD
Phenobarbital—Hepatitis—Epirubicin—testicular cancer	0.000175	0.00182	CcSEcCtD
Phenobarbital—Nausea—Ifosfamide—testicular cancer	0.000167	0.00173	CcSEcCtD
Phenobarbital—Erythema multiforme—Epirubicin—testicular cancer	0.000165	0.00172	CcSEcCtD
Phenobarbital—Bradycardia—Doxorubicin—testicular cancer	0.000165	0.00171	CcSEcCtD
Phenobarbital—Hypersensitivity—Etoposide—testicular cancer	0.000163	0.0017	CcSEcCtD
Phenobarbital—Erythema—Methotrexate—testicular cancer	0.000163	0.00169	CcSEcCtD
Phenobarbital—Hepatitis—Doxorubicin—testicular cancer	0.000162	0.00168	CcSEcCtD
Phenobarbital—Vomiting—Cisplatin—testicular cancer	0.000154	0.0016	CcSEcCtD
Phenobarbital—Erythema multiforme—Doxorubicin—testicular cancer	0.000153	0.00159	CcSEcCtD
Phenobarbital—Rash—Cisplatin—testicular cancer	0.000153	0.00158	CcSEcCtD
Phenobarbital—Dermatitis—Cisplatin—testicular cancer	0.000152	0.00158	CcSEcCtD
Phenobarbital—Erythema—Epirubicin—testicular cancer	0.000152	0.00158	CcSEcCtD
Phenobarbital—Tension—Epirubicin—testicular cancer	0.000149	0.00155	CcSEcCtD
Phenobarbital—Nervousness—Epirubicin—testicular cancer	0.000148	0.00154	CcSEcCtD
Phenobarbital—Dizziness—Etoposide—testicular cancer	0.000147	0.00152	CcSEcCtD
Phenobarbital—Vertigo—Methotrexate—testicular cancer	0.000146	0.00152	CcSEcCtD
Phenobarbital—Nausea—Cisplatin—testicular cancer	0.000144	0.00149	CcSEcCtD
Phenobarbital—Vomiting—Etoposide—testicular cancer	0.000141	0.00146	CcSEcCtD
Phenobarbital—ABCB1—lymph node—testicular cancer	0.000141	0.00231	CbGeAlD
Phenobarbital—Erythema—Doxorubicin—testicular cancer	0.000141	0.00146	CcSEcCtD
Phenobarbital—Agitation—Epirubicin—testicular cancer	0.00014	0.00145	CcSEcCtD
Phenobarbital—Rash—Etoposide—testicular cancer	0.00014	0.00145	CcSEcCtD
Phenobarbital—Dermatitis—Etoposide—testicular cancer	0.00014	0.00145	CcSEcCtD
Phenobarbital—Headache—Etoposide—testicular cancer	0.000139	0.00144	CcSEcCtD
Phenobarbital—Myalgia—Methotrexate—testicular cancer	0.000138	0.00144	CcSEcCtD
Phenobarbital—Arthralgia—Methotrexate—testicular cancer	0.000138	0.00144	CcSEcCtD
Phenobarbital—Tension—Doxorubicin—testicular cancer	0.000138	0.00144	CcSEcCtD
Phenobarbital—Nervousness—Doxorubicin—testicular cancer	0.000137	0.00142	CcSEcCtD
Phenobarbital—Vertigo—Epirubicin—testicular cancer	0.000137	0.00142	CcSEcCtD
Phenobarbital—Syncope—Epirubicin—testicular cancer	0.000136	0.00142	CcSEcCtD
Phenobarbital—Confusional state—Methotrexate—testicular cancer	0.000134	0.00139	CcSEcCtD
Phenobarbital—Loss of consciousness—Epirubicin—testicular cancer	0.000134	0.00139	CcSEcCtD
Phenobarbital—Nausea—Etoposide—testicular cancer	0.000132	0.00137	CcSEcCtD
Phenobarbital—Myalgia—Epirubicin—testicular cancer	0.00013	0.00135	CcSEcCtD
Phenobarbital—Arthralgia—Epirubicin—testicular cancer	0.00013	0.00135	CcSEcCtD
Phenobarbital—Agitation—Doxorubicin—testicular cancer	0.000129	0.00134	CcSEcCtD
Phenobarbital—Anxiety—Epirubicin—testicular cancer	0.000129	0.00134	CcSEcCtD
Phenobarbital—Vertigo—Doxorubicin—testicular cancer	0.000127	0.00131	CcSEcCtD
Phenobarbital—Syncope—Doxorubicin—testicular cancer	0.000126	0.00131	CcSEcCtD
Phenobarbital—Confusional state—Epirubicin—testicular cancer	0.000125	0.0013	CcSEcCtD
Phenobarbital—Hypotension—Methotrexate—testicular cancer	0.000124	0.00129	CcSEcCtD
Phenobarbital—Loss of consciousness—Doxorubicin—testicular cancer	0.000124	0.00129	CcSEcCtD
Phenobarbital—Shock—Epirubicin—testicular cancer	0.000122	0.00127	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000121	0.00126	CcSEcCtD
Phenobarbital—Arthralgia—Doxorubicin—testicular cancer	0.00012	0.00125	CcSEcCtD
Phenobarbital—Myalgia—Doxorubicin—testicular cancer	0.00012	0.00125	CcSEcCtD
Phenobarbital—Anxiety—Doxorubicin—testicular cancer	0.000119	0.00124	CcSEcCtD
Phenobarbital—Somnolence—Methotrexate—testicular cancer	0.000118	0.00123	CcSEcCtD
Phenobarbital—Hypotension—Epirubicin—testicular cancer	0.000116	0.00121	CcSEcCtD
Phenobarbital—Confusional state—Doxorubicin—testicular cancer	0.000116	0.0012	CcSEcCtD
Phenobarbital—Pain—Methotrexate—testicular cancer	0.000114	0.00118	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000113	0.00118	CcSEcCtD
Phenobarbital—Shock—Doxorubicin—testicular cancer	0.000113	0.00117	CcSEcCtD
Phenobarbital—Somnolence—Epirubicin—testicular cancer	0.00011	0.00115	CcSEcCtD
Phenobarbital—Feeling abnormal—Methotrexate—testicular cancer	0.000109	0.00114	CcSEcCtD
Phenobarbital—Hypotension—Doxorubicin—testicular cancer	0.000107	0.00112	CcSEcCtD
Phenobarbital—Constipation—Epirubicin—testicular cancer	0.000106	0.0011	CcSEcCtD
Phenobarbital—Pain—Epirubicin—testicular cancer	0.000106	0.0011	CcSEcCtD
Phenobarbital—Urticaria—Methotrexate—testicular cancer	0.000105	0.0011	CcSEcCtD
Phenobarbital—Body temperature increased—Methotrexate—testicular cancer	0.000105	0.00109	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000105	0.00109	CcSEcCtD
Phenobarbital—Feeling abnormal—Epirubicin—testicular cancer	0.000102	0.00106	CcSEcCtD
Phenobarbital—Somnolence—Doxorubicin—testicular cancer	0.000102	0.00106	CcSEcCtD
Phenobarbital—Urticaria—Epirubicin—testicular cancer	9.87e-05	0.00102	CcSEcCtD
Phenobarbital—Constipation—Doxorubicin—testicular cancer	9.83e-05	0.00102	CcSEcCtD
Phenobarbital—Pain—Doxorubicin—testicular cancer	9.83e-05	0.00102	CcSEcCtD
Phenobarbital—Body temperature increased—Epirubicin—testicular cancer	9.82e-05	0.00102	CcSEcCtD
Phenobarbital—Hypersensitivity—Methotrexate—testicular cancer	9.78e-05	0.00102	CcSEcCtD
Phenobarbital—Feeling abnormal—Doxorubicin—testicular cancer	9.47e-05	0.000984	CcSEcCtD
Phenobarbital—Hypersensitivity—Epirubicin—testicular cancer	9.15e-05	0.00095	CcSEcCtD
Phenobarbital—Urticaria—Doxorubicin—testicular cancer	9.13e-05	0.000948	CcSEcCtD
Phenobarbital—Body temperature increased—Doxorubicin—testicular cancer	9.09e-05	0.000944	CcSEcCtD
Phenobarbital—Dizziness—Methotrexate—testicular cancer	8.78e-05	0.000912	CcSEcCtD
Phenobarbital—Hypersensitivity—Doxorubicin—testicular cancer	8.47e-05	0.000879	CcSEcCtD
Phenobarbital—Vomiting—Methotrexate—testicular cancer	8.44e-05	0.000876	CcSEcCtD
Phenobarbital—Rash—Methotrexate—testicular cancer	8.37e-05	0.000869	CcSEcCtD
Phenobarbital—Dermatitis—Methotrexate—testicular cancer	8.36e-05	0.000868	CcSEcCtD
Phenobarbital—Headache—Methotrexate—testicular cancer	8.32e-05	0.000864	CcSEcCtD
Phenobarbital—Dizziness—Epirubicin—testicular cancer	8.21e-05	0.000853	CcSEcCtD
Phenobarbital—Vomiting—Epirubicin—testicular cancer	7.9e-05	0.00082	CcSEcCtD
Phenobarbital—Nausea—Methotrexate—testicular cancer	7.88e-05	0.000819	CcSEcCtD
Phenobarbital—Rash—Epirubicin—testicular cancer	7.83e-05	0.000813	CcSEcCtD
Phenobarbital—Dermatitis—Epirubicin—testicular cancer	7.83e-05	0.000813	CcSEcCtD
Phenobarbital—Headache—Epirubicin—testicular cancer	7.78e-05	0.000808	CcSEcCtD
Phenobarbital—Dizziness—Doxorubicin—testicular cancer	7.6e-05	0.000789	CcSEcCtD
Phenobarbital—Nausea—Epirubicin—testicular cancer	7.38e-05	0.000766	CcSEcCtD
Phenobarbital—Vomiting—Doxorubicin—testicular cancer	7.31e-05	0.000759	CcSEcCtD
Phenobarbital—Rash—Doxorubicin—testicular cancer	7.25e-05	0.000753	CcSEcCtD
Phenobarbital—Dermatitis—Doxorubicin—testicular cancer	7.24e-05	0.000752	CcSEcCtD
Phenobarbital—Headache—Doxorubicin—testicular cancer	7.2e-05	0.000748	CcSEcCtD
Phenobarbital—Nausea—Doxorubicin—testicular cancer	6.83e-05	0.000709	CcSEcCtD
